BRIDGET HOPSON: Open Payments
NPI 1477005429 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 45 payments from 10 companies in 2025. Trend: 2023 $872 · 2024 $1,170 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $365 |
| Lilly USA, LLC | 10 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $96 |
| Novo Nordisk Inc | 3 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| Dexcom, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: AIRSUPRA, MOUNJARO, BREZTRI, Kerendia, JARDIANCE, Ozempic, FARXIGA, Rybelsus.
Industry payments across TX — which companies pay providers there.
